CRP and ankylosing spondylitis: The outcomes assessed were ≥20% improvement in the Assessment of Spondyloarthritis International Society Criteria (ASAS20), Bath Ankylosing Spondylitis Functional Index (BASFI), and C-reactive protein (CRP) at weeks 12-16.